Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2027 346

  1. Study completion A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07394114

  2. Primary completion Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07552194

  3. Study completion DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07229248

  4. Primary completion Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684144

  5. Primary completion The RESET System Pivotal Clinical Trial (Protocol Revision K) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04101669

  6. Study completion Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04347434

  7. Study completion Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04797572

  8. Primary completion Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05712200

  9. Primary completion Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05817851

  10. Study completion Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06284642

  11. Study completion Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06548204

  12. Study completion Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06769256

  13. Primary completion Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus Burden Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06769256

  14. Study completion Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06936176

  15. Primary completion Prospective Trial of IVL for Calcified Carotid Lesions(CREATE Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06936176

  16. Study completion REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07006493

  17. Study completion Early Screening and Treatment of Heart Complication in Sickle Cell Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07023666

  18. Primary completion Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial(HERO -aCKD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07027774

  19. Primary completion The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07027891

  20. Study completion Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07048808

  21. Study completion The Role of Swan-Ganz Catheter in Hemodynamic Resuscitation for Patients With Cardiogenic Shock Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07062744

  22. Study completion Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07135089

  23. Primary completion The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07162792

  24. Study completion Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07283159

  25. Study completion Targeted Temperature Management Via Bladder Monitoring in ICH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07302009

  26. Primary completion Targeted Temperature Management Via Bladder Monitoring in ICH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07302009

  27. Study completion Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07307235

  28. Study completion Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07375953

  29. Primary completion Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07375953

  30. Study completion Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07375966

  31. Primary completion Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Tenecteplase (RITIS-TNK2) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07375966

  32. Primary completion Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07531394

  33. Study completion Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07550296

  34. Primary completion Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07550296

  35. Study completion A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07645586

  36. Study start Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739888

  37. Study completion Clinical Trial of Thrombectomy Systems Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07749820

  38. Primary completion Clinical Trial of Thrombectomy Systems Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07749820

  39. Primary completion Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07751965

  40. Primary completion Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07877103

  41. Study completion Sensory-Motor Rehabilitation Post Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02369770

  42. Primary completion Sensory-Motor Rehabilitation Post Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02369770

  43. Study completion Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02489539

  44. Primary completion Molecular Imaging of Primary Amyloid Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02641145

  45. Study completion Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03218137

  46. Primary completion Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03218137

  47. Study completion Quelling of Excitotoxicity in Acute Stroke With Ketamine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03223220

  48. Study completion Coronary Atherosclerosis T1-Weighted Characterization (CATCH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03504956

  49. Study completion Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03586336

  50. Primary completion Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03586336

  51. Primary completion Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04097145

  52. Primary completion AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04225520

  53. Primary completion Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04258488

  54. Study completion COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04642430

  55. Primary completion COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04642430

  56. Study completion GOREISAN for Heart Failure (GOREISAN-HF) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04691700

  57. Primary completion GOREISAN for Heart Failure (GOREISAN-HF) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04691700

  58. Study completion Remote Ischaemic Conditioning in STEMI Patients in AFRICA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04813159

  59. Primary completion Remote Ischaemic Conditioning in STEMI Patients in AFRICA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04813159

  60. Study completion TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04951050

  61. Primary completion Hypertonic Lactate After Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05004610

  62. Study completion Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05286710

  63. Study completion Pain Reduction Using NEurostimulation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05311956

  64. Study completion Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05410925

  65. Primary completion OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05418556

  66. Study completion To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05426785

  67. Study completion PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05493904

  68. Study completion The Leadless AV Versus DDD Pacing Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05498376

  69. Study completion Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05507749

  70. Study completion Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05560204

  71. Study completion Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05569382

  72. Study completion SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05583773

  73. Study completion HOST - DAPT Duration According the Bleeding Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05631769

  74. Primary completion Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05679024

  75. Primary completion Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05744219

  76. Primary completion Chronic Coronary Syndrome in Swedish Primary Care Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05782582

  77. Primary completion Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Drug-eluting Stent Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05955365

  78. Study completion Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06007222

  79. Study completion Intracardiac Echocardiography Guided Watchman Device Implant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06007872

  80. Primary completion Intracardiac Echocardiography Guided Watchman Device Implant Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06007872

  81. Study completion Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06013020

  82. Primary completion The MAGiC™ Cardiac Ablation European Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06019845

  83. Study completion The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06059664

  84. Study completion Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06108414

  85. Primary completion Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06115070

  86. Study completion Arresting Early Childhood Caries With a Silver Diamine Fluoride Gel Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06241261

  87. Primary completion EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249945

  88. Study completion Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06281899

  89. Primary completion Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06281899

  90. Study completion CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06304857

  91. Study completion Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06308952

  92. Study completion Home Grip Assistance Glove on the Use of the Upper Limb and Compliance Factors in Brain-injured Adults Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06312631

  93. Primary completion Home Grip Assistance Glove on the Use of the Upper Limb and Compliance Factors in Brain-injured Adults Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06312631

  94. Study completion Stroke Alarm Efficacy Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06315192

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients. Registry record

    Expected 2022-01-15; that period ended on 2022-01-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04457323

  2. Study completion Second-generation Drug-eluting Stents in Diabetes Registry record

    Expected 2022-01-28; that period ended on 2022-01-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03321032

  3. Study completion Comparison of Low-radiation Dose CT Angiography With Invasive Coronary Angiography in Stable Coronary Disease Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01476579

  4. Study completion FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02943954

  5. Primary completion Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03041259

  6. Study completion MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03705312

  7. Study completion rTMS and Robotic Gait Training in Patients With Stroke Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03817385

  8. Primary completion VitaFlow™ II Transcatheter Aortic Valve System Pre-market Trial Registry record

    Expected 2022-01-31; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04414878

  9. Study completion CUHK Jockey Club Tech-based Stroke Rehabilitation Programme - ARR Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04638218

  10. Primary completion CUHK Jockey Club Tech-based Stroke Rehabilitation Programme - ARR Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04638218

  11. Primary completion A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin Registry record

    Expected 2022-01-31; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04706637

  12. Study start Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04786769

  13. Study completion Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. Registry record

    Expected 2022-01-31; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04858308

  14. Primary completion Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04955145

  15. Study start Rotablation vs Intravascular Lithotripsy in Calcified Coronary Lesions Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04960319

  16. Study start Assessment of Intracerebral Hematoma Registry record

    Expected 2022-01; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05158660

  17. Study completion Post-market Registry to Assess the Clinical Performance and Safety of the Passeo-18 Lux in Infrainguinal Arteries Registry record

    Expected 2022-01-31; that period ended on 2022-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05175703

  18. Primary completion Randomization of Endovascular Treatment in Acute Ischemic Stroke in the Extended Time Window Registry record

    Expected 2022-02-01; that period ended on 2022-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04256096

  19. Study completion Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS® Registry record

    Expected 2022-02-01; that period ended on 2022-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04570865

  20. Primary completion Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Registry record

    Expected 2022-02-01; that period ended on 2022-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04686643

  21. Study start Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions Registry record

    Expected 2022-02-01; that period ended on 2022-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05200637

  22. Study completion Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 Registry record

    Expected 2022-02-02; that period ended on 2022-02-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04161001

  23. Primary completion Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. Registry record

    Expected 2022-02-02; that period ended on 2022-02-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04229264

  24. Primary completion Efficacy of rTMS and VCT on Upper Limb Function in Patients With Stroke Registry record

    Expected 2022-02-11; that period ended on 2022-02-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03350087

  25. Primary completion Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds Registry record

    Expected 2022-02; that period ended on 2022-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04504864

  26. Study completion Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients Registry record

    Expected 2022-02; that period ended on 2022-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04955145

  27. Primary completion Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myocardial Infarction Registry record

    Expected 2022-03-01; that period ended on 2022-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04695990

  28. Study completion Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis Registry record

    Expected 2022-03-01; that period ended on 2022-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04709770

  29. Primary completion Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis Registry record

    Expected 2022-03-01; that period ended on 2022-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04709770

  30. Study start THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein Registry record

    Expected 2022-03-01; that period ended on 2022-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05194423

  31. Study start Novel Brain Neurotechnology for Optimizing Precision Mirror Therapy in Stroke Registry record

    Expected 2022-03-01; that period ended on 2022-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05238272

  32. Study completion Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia Registry record

    Expected 2022-03-15; that period ended on 2022-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04438096

  33. Study start Reducing Edema After intraCerebral Hemorrhage Registry record

    Expected 2022-03-15; that period ended on 2022-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05263167

  34. Study start Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA) Registry record

    Expected 2022-03-15; that period ended on 2022-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05282836

  35. Study completion CHOCO-CABANA Trial Registry record

    Expected 2022-03-27; that period ended on 2022-03-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04539145

  36. Primary completion CHOCO-CABANA Trial Registry record

    Expected 2022-03-27; that period ended on 2022-03-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04539145

  37. Primary completion Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) Registry record

    Expected 2022-03-30; that period ended on 2022-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03786757

  38. Primary completion The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients Registry record

    Expected 2022-03-30; that period ended on 2022-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04365517

  39. Study completion aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02513797

  40. Study completion Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead Registry record

    Expected 2022-03-31; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03110627

  41. Primary completion Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients With the Use of a VDD-ICD Lead Registry record

    Expected 2022-03-31; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03110627

  42. Study completion Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03279484

  43. Study completion Comparative Analysis in Detection of Atrial Arrhythmia and ECG Quality in Three Different Insertable Cardiac Monitors Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04471584

  44. Primary completion A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04562142

  45. Primary completion The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04912167

  46. Study start Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05217485

  47. Study start Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study Registry record

    Expected 2022-03; that period ended on 2022-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05263778

  48. Primary completion Physician Optimised Post-partum Hypertension Treatment Trial Registry record

    Expected 2022-04-01; that period ended on 2022-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04273854

  49. Primary completion The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement Registry record

    Expected 2022-04-01; that period ended on 2022-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04573049

  50. Primary completion Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients Registry record

    Expected 2022-04-01; that period ended on 2022-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05070494

  51. Study start ROBOtic Care of Post-stroke Pain. Registry record

    Expected 2022-04-01; that period ended on 2022-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05288270

  52. Study start Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia Registry record

    Expected 2022-04-01; that period ended on 2022-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05289518

  53. Study start Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome Registry record

    Expected 2022-04-01; that period ended on 2022-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05298475

  54. Primary completion AUSTrian Randomized Interventional Study on Dialysis Accesses Registry record

    Expected 2022-04-04; that period ended on 2022-04-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03764358

  55. Study start To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Expected 2022-04-05; that period ended on 2022-04-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05296044

  56. Study start Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection Registry record

    Expected 2022-04-20; that period ended on 2022-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05331495

  57. Primary completion Citicoline in Ischemic Stroke Registry record

    Expected 2022-04-22; that period ended on 2022-04-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05154903

  58. Study completion Trial of MiStent Compared to Xience in Japan Registry record

    Expected 2022-04-30; that period ended on 2022-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02972671

  59. Primary completion Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension Registry record

    Expected 2022-04; that period ended on 2022-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03254446

  60. Primary completion Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH Registry record

    Expected 2022-04; that period ended on 2022-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04702490

  61. Study completion Metformin in Diabetic Patients Undergoing Coronary Angiography Registry record

    Expected 2022-04-30; that period ended on 2022-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04766008

  62. Primary completion Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus Registry record

    Expected 2022-04; that period ended on 2022-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04817215

  63. Study completion Randomization of Endovascular Treatment in Acute Ischemic Stroke in the Extended Time Window Registry record

    Expected 2022-05-01; that period ended on 2022-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04256096

  64. Primary completion Procedural Outcomes of Percutaneous PDA Closure: Comparative Study Between Different Devices. Registry record

    Expected 2022-05-01; that period ended on 2022-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04303793

  65. Study completion Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Registry record

    Expected 2022-05-01; that period ended on 2022-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04686643

  66. Study start Echocardiography by Non-cardiologist in Early Management of Patients With Chest Pain Registry record

    Expected 2022-05-01; that period ended on 2022-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05306730

  67. Study completion Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients. Registry record

    Expected 2022-05-02; that period ended on 2022-05-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04229264

  68. Study completion To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia Registry record

    Expected 2022-05-19; that period ended on 2022-05-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04659070

  69. Primary completion To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia Registry record

    Expected 2022-05-19; that period ended on 2022-05-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04659070

  70. Primary completion A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone Registry record

    Expected 2022-05-30; that period ended on 2022-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04255238

  71. Study start Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy Registry record

    Expected 2022-05-30; that period ended on 2022-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05326490

  72. Primary completion Intervention for Monitoring of Salt Intake in Hypertensive Patients Registry record

    Expected 2022-05-30; that period ended on 2022-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05397054

  73. Study completion Mandibular Advancement Device for Treatment of Obstructive Sleep Apnea and Its Impact on Cardiac Remodeling Registry record

    Expected 2022-05-31; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02948894

  74. Study completion Efficacy of rTMS and VCT on Upper Limb Function in Patients With Stroke Registry record

    Expected 2022-05-31; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03350087

  75. Study completion RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD Registry record

    Expected 2022-05; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03789695

  76. Study completion Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study Registry record

    Expected 2022-05-31; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04327232

  77. Primary completion Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study Registry record

    Expected 2022-05-31; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04327232

  78. Study completion A Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease The CAD-det Validation Study Registry record

    Expected 2022-05; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04562142

  79. Study completion Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Registry record

    Expected 2022-05; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04834089

  80. Primary completion Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Registry record

    Expected 2022-05; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04834089

  81. Study start The Use of a Monitoring Device by General Practitioners During Out-of-hours Care Registry record

    Expected 2022-05; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05222711

  82. Study start ThrombX Retriever for Acute Ischemic Stroke Trial Registry record

    Expected 2022-05; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05270122

  83. Study completion Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-II) Registry record

    Expected 2022-05-31; that period ended on 2022-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05281549

  84. Study completion Safety and Performance Study of the MitralStitch Repair System. Registry record

    Expected 2022-06-01; that period ended on 2022-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04080362

  85. Primary completion Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome Registry record

    Expected 2022-06-01; that period ended on 2022-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04100434

  86. Study completion Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery Registry record

    Expected 2022-06-01; that period ended on 2022-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04223739

  87. Primary completion Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery Registry record

    Expected 2022-06-01; that period ended on 2022-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04340908

  88. Study start Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial) Registry record

    Expected 2022-06-01; that period ended on 2022-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04523649

  89. Study completion Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION) Registry record

    Expected 2022-06-15; that period ended on 2022-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04734353

  90. Study start A Study of TG103 Injection in Type 2 Diabetes Subjects Registry record

    Expected 2022-06-15; that period ended on 2022-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05348122

  91. Study completion Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions. Registry record

    Expected 2022-06-22; that period ended on 2022-06-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03721614

  92. Study completion Citicoline in Ischemic Stroke Registry record

    Expected 2022-06-22; that period ended on 2022-06-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05154903

  93. Study completion Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02208765

  94. Primary completion Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02208765

  95. Study completion PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02895737

  96. Study start Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02988245

  97. Primary completion Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03535935

  98. Primary completion Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03728738

  99. Primary completion Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction Registry record

    Expected 2022-06-30; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03753269

  100. Study start A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH Registry record

    Expected 2022-06; that period ended on 2022-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03970031